Posts tagged with: "Enlarged-Board-of-Appeal"
Results 1021 - 1040
of 1,196
Sorted by Relevance
|
Sort by Date
4 Jun 2010, 5:55 am
The May 2010 programme (now online) covers, inter alia, (i) a failed attempt to use the tort of causing unfair harm by unlawful means, where there was no IP to rely on; (ii) the Advocate General finding levies on equipment and media incompatible with the Information Society Directive; (iii) a replica of Henry the vacuum cleaner that infringed no design rights but fell foul of passing-off law; (iv) the EPO's Enlarged Board of Appeal rejecting the referral of questions… [read post]
7 Dec 2010, 9:01 am
The Appellants appealed both orders. [read post]
24 Dec 2024, 4:40 am
In its decisions the Dutch court addressed two pivotal aspects: (formal) priority of the patent in light of the G 1/22 and G 2/22 decisions of the Enlarged Board of Appeal (EBA); and inventive step in light of the EBA’s G 2/21 decision to determine whether BMS could rely on the purported technical effect. [read post]
11 Apr 2021, 11:38 am
However, the EUIPO Third Board of Appeal (“BoA''), before which the Cancellation Division's decision had been appealed, declared the Contested Design invalid (the “Contested Decision”). [read post]
15 Sep 2015, 1:39 am
Never too late 59 [week ending on Sunday 16 August] - Fundamental deficiency in an EPO decision need not be a problem |Benedict Cumberbatch versus admiring audience | Emma Perot on graffiti as dress art | Location of London's division of the UPC | Cool, confident and healthy: Katonomy meets Jawbone and Fitbit |Planning permission and that London UPC venue |Partial priority and poisonous provisionals: questions for EPO Enlarged… [read post]
13 Feb 2019, 10:04 am
He appealed to the Environmental Court. [read post]
5 Apr 2016, 6:32 am
Swiss-type claims take the form:"use of a drug X in the manufacture/preparation of a medicament for the treatment of disease Y"EPC 2000 claims take the form of: "Drug X for the treatment of disease Y"The European Patent Office's Technical Board of Appeal (TBA) have told us that these claims are not synonymous in scope (see T 1780/12 - University of Texas) and you cannot amend from one to another. [read post]
14 Dec 2011, 8:06 pm
The Enlarged Board (EBA) did not agree:[2] Pursuant to R 106 a petition for review based on a fundamental procedural violation under A 112a paragraph 2(a) to (d) is only admissible where an objection in respect of the procedural defect was raised during the appeal proceedings and dismissed by the BoA, except where such objection could not be raised during the appeal proceedings. [2.1] Raising an objection pursuant to R 106 is a procedural act and a precondition… [read post]
31 Jul 2024, 1:14 am
An outcome in favour of the patentee is always more likely before the Opposition Division than before the Board of Appeal. [read post]
1 Mar 2012, 5:01 pm
However, as will be explained in point [7] below [wherein the Board demonstrates the novelty of claim 1], this does not hold true for the use claims any more […]. [read post]
3 Oct 2013, 10:59 am
About nine months after the IDV directives were issued, in consultation with the Administrative Board and with the consent of the Court of Appeals, the Chief Judge promulgated part 42 of the Rules of the Chief Judge establishing a criminal division in the Supreme Court in Bronx County. [read post]
29 Jul 2012, 5:01 pm
In 2010, Board 3.5.03 (case T 1145/09) referred the following questions to the Enlarged Board (EBA) :1. [read post]
24 Oct 2023, 11:15 am
The Patent Trial and Appeal Board (the “PTAB”) instituted review on both patents and concluded that claims 10, 11, 13, 17, and 23 of the ’698 patent and claims 1, 2, 4, and 13-18 of the ’196 patent were unpatentable as anticipated and/or obvious in view of the prior art. [read post]
20 Aug 2011, 2:45 pm
Francis Victor Coutinho (1980) 3 SCC 223, this Court held that local authority is entitled to be impleaded as a party in the proceedings before the Reference Court and in case the amount of compensation is enhanced by the Court, the local authority can file an appeal with the leave of the Court subject to the condition that no appeal is filed by the Government. [read post]
24 Jan 2011, 3:01 pm
The application discloses no data for any other animal model study with a different experimental design, nor for any test carried out with humans. [6] Where a therapeutic application is claimed in the form allowed by the Enlarged Board of Appeal in its decision G 5/83, i.e. in the form of the use of a substance or composition for the manufacture of a medicament for a defined therapeutic application, attaining the claimed therapeutic effect is a functional technical feature… [read post]
24 Aug 2012, 11:27 am
Any additional motions to amend will require prior authorization by the Patent Trial and Appeal Board. [read post]
1 May 2011, 3:01 pm
As a consequence, the conditions for the legal fiction set out in Enlarged Board of Appeal decision G 5/83 directly applied.The Board sees things in a different light:[2.1] Methods for treatment of the human and animal body by surgery are listed among the methods excluded from patentability according to A 52(4) EPC 1973 (A 53(c) EPC 2000). [read post]
1 Mar 2015, 4:19 am
The UK already has a doctrine of poisonous priorities (see Katpost here) and now the EPO Enlarged Board is going to be thinking about it too in a referral from appeal proceedings on T557/13.Complexity: added matter and who is being protected? [read post]
27 Apr 2015, 3:56 am
Never too late 39 [week ending Sunday 29 March] – Merpel writes to the EPO AC | CJEU and hyperlinks | New gTLD regime | AG on TM reputation and genuine use in Case C‑125/14 Iron & Smith Kft v Unilever NV | AMBA speaks | Digital exhaustion | CJEU on linking to live shows in Case C-279/13 C More Entertainment| EPO Enlarged Board on amendments’ clarity in G 3/14 | EPO on patentability in cases G 2/12… [read post]
30 Apr 2019, 5:29 am
Aloys addressed the difficult political implications of this decision, leaving it unclear whether next steps should be expected from the Enlarged Board of Appeal (there was a recent referral by the EPO president, from the Administrative Council (which could amend Art. 53 EPC regarding the exceptions to patentability), from the European Commission (which could give guidance on the Biotech Directive), or from the EPC Member States (who according to Aloys appear to be… [read post]
